Emisphere Technologies, Inc. (EMIS) - OTCQB
Company Description
Emisphere is a specialty pharmaceutical company that has recently commenced commercial operations. The Company launched its first prescription product, oral Eligen B12, in the U.S. in March 2015. Beyond Eligen B12, the Company utilizes its proprietary Eligen Technology to create new oral... More
Sector: Healthcare
Industry: Drug Delivery & Accessories
Country: United States